Les 10 concurrents sterispharma.com les plus visités

sterisonline.com

Steris healthcare offering the PCD pharma Franchise For third party medicine distributors, upload prescription and order medicine with quality and affordable rate.

sterisindia.com

IMATIFLOW 400, containing Imatinib IP 400mg, represents a breakthrough in targeted cancer therapy, offering patients a precise weapon against specific malignancies. This oral medication belongs to the class of tyrosine kinase inhibitors, revolutionizing treatment for conditions once deemed challenging to manage. By blocking abnormal proteins that fuel cancer cell growth, IMATIFLOW 400 helps restore normal cellular function and improves quality of life for many users.​ Product Overview IMATIFLOW 400 is a branded formulation of Imatinib mesylate 400mg, produced to high pharmaceutical standards for consistent efficacy and bioavailability. Each tablet delivers the active ingredient in a film-coated form, designed for once-daily administration with food to enhance absorption and minimize gastrointestinal upset. Developed for adult patients, it targets cancers driven by dysregulated tyrosine kinases like BCR-ABL, c-KIT, and PDGFR, making it a cornerstone in modern oncology protocols.​ The medication's mechanism hinges on competitive inhibition at the ATP-binding site of these kinases, halting downstream signaling pathways that promote uncontrolled proliferation, survival, and metastasis of malignant cells. Unlike traditional chemotherapy, which broadly attacks dividing cells, IMATIFLOW 400 spares most healthy tissues, leading to a more favorable safety profile. Clinical data from pivotal trials underscore its role as first-line therapy, with high response rates observed within months of initiation.​ Primary Uses IMATIFLOW 400 excels in treating chronic myeloid leukemia (CML), particularly in the chronic phase where it induces deep molecular responses in over 80% of patients. It suppresses the Philadelphia chromosome-positive cells hallmark of CML by inhibiting the BCR-ABL fusion protein, dramatically extending progression-free survival. For newly diagnosed patients, standard dosing starts at 400mg daily, often achieving complete cytogenetic remission.​ In gastrointest

wockhardt.com

Wockhardt is a leading, research-based global enterprise in pharmaceuticals, biotechnology and healthcare services.

gsk.com

At GSK, we unite science, technology and talent to get ahead of disease together

huons.com

인류 건강의 해결책을 제시하는 휴온스, 코스닥 상장사, 치과 국소마취제, 다이어트엔 알룬정

hipra.com

we're a pharmaceutical company focused on prevention & diagnosis. we're putting our minds and passion into developing vaccines that are different

dapharm.com

This is Dong-A Pharmaceutical, your global partner in consumer healthcare. Discover a comprehensive range of healthcare products, including BACCHUS, over-the-counter medicines (OTC), health functional foods, and cosmetics. Stay updated on our latest research and development initiatives and corporate news.

indizenpharma.com

Indizen Pharmaceutical is known as Top Pcd Pharma Franchise Company in India. Explore lucrative franchise opportunities with us. Contact us now!